US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
GB9106686D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US6875420B1
(en)
|
1991-09-17 |
2005-04-05 |
Amersham Health As |
Method of ultrasound imaging
|
US6723303B1
(en)
|
1991-09-17 |
2004-04-20 |
Amersham Health, As |
Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
|
MX9205298A
(es)
*
|
1991-09-17 |
1993-05-01 |
Steven Carl Quay |
Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
|
GB9200388D0
(en)
*
|
1992-01-09 |
1992-02-26 |
Nycomed As |
Improvements in or relating to contrast agents
|
IL108416A
(en)
|
1993-01-25 |
1998-10-30 |
Sonus Pharma Inc |
Colloids with phase difference as contrast ultrasound agents
|
CZ191695A3
(en)
*
|
1993-01-25 |
1996-05-15 |
Sonus Pharma Inc |
Biologically compatible contrast agent, process of its preparation and representation method by ultrasound
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
DE4406474A1
(de)
|
1994-02-23 |
1995-08-24 |
Schering Ag |
Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
DE69736981D1
(de)
|
1996-05-01 |
2007-01-04 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
WO1998010798A1
(en)
|
1996-09-11 |
1998-03-19 |
Imarx Pharmaceutical Corp. |
Improved methods for diagnostic imaging using a contrast agent and a vasodilator
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US20050019266A1
(en)
*
|
1997-05-06 |
2005-01-27 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
AU1705300A
(en)
*
|
1998-10-12 |
2000-05-01 |
Mallinckrodt, Inc. |
Novel ultrasound contrast agents
|
US6514209B1
(en)
|
1999-06-07 |
2003-02-04 |
Drexel University |
Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals
|
JP5078212B2
(ja)
|
2000-06-02 |
2012-11-21 |
ブラッコ・スイス・ソシエテ・アノニム |
内皮細胞を標的とするための化合物、それを含む組成物およびその使用方法
|
WO2002080774A2
(en)
*
|
2001-04-06 |
2002-10-17 |
Bracco Research S.A. |
Method for improved measurement of local physical parameters in afluid-filled cavity
|
DE10119522A1
(de)
*
|
2001-04-20 |
2002-12-05 |
Innovacell Biotechnologie Gmbh |
Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
|
US7087212B2
(en)
*
|
2001-08-17 |
2006-08-08 |
Mallinckrodt, Inc |
Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
|
US7211240B2
(en)
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
WO2004065621A1
(en)
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
US7794693B2
(en)
*
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
CA2666005C
(en)
|
2002-03-01 |
2016-01-19 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
JP3664401B2
(ja)
*
|
2003-01-22 |
2005-06-29 |
独立行政法人科学技術振興機構 |
N−グリコシド型糖脂質及びこれから成る中空繊維状有機ナノチューブ
|
US20060235296A1
(en)
*
|
2003-02-13 |
2006-10-19 |
Bracco Imaging S.P.A. |
Contrast enhanced x-ray phase imaging
|
US20050214859A1
(en)
|
2003-03-03 |
2005-09-29 |
Dyax Corp. |
Peptides that specifically bind HGF receptor (cMet) and uses thereof
|
US20040258760A1
(en)
*
|
2003-03-20 |
2004-12-23 |
Wheatley Margaret A. |
Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
|
US8012457B2
(en)
*
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
WO2007137236A2
(en)
*
|
2006-05-19 |
2007-11-29 |
Drexel University |
Drug loaded contrast agents: combining diagnosis and therapy
|
WO2012136813A2
(en)
|
2011-04-07 |
2012-10-11 |
Universitetet I Oslo |
Agents for medical radar diagnosis
|
MX2017008721A
(es)
|
2014-12-31 |
2017-11-17 |
Lantheus Medical Imaging Inc |
Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.
|
CA3022698A1
(en)
|
2016-05-04 |
2017-11-09 |
Lantheus Medical Imaging, Inc. |
Methods and devices for preparation of ultrasound contrast agents
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|